TGTX TG Therapeutics Inc

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

$4.57  +0.32 (7.53%)
As of 07/01/2022 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  144,435,369
Average volume:  3,915,231
Market cap:   $623,960,794
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B828K63
Valuation   (See tab for details)
PE ratio:   -1.91
PB ratio:   3.32
PS ratio:   78.86
Return on equity:   -191.62%
Net income %:   -4,126.47%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy